Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jeffrey Coco"'
Autor:
Lisa A. Taylor, Michelle Brock, Jeffrey Coco, Collette Cook, Lauren A. Holian, Erin C. Powell
Publikováno v:
Ethology. 125:351-361
Predators often avoid aposematic prey as a result of aversions to particular prey signals (e.g., bright colours and noxious odours). These aversions may be flexible, that is, they can be reinforced or extinguished with experience. As such, we might e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6378173c8fd74bd26edc0723e3ba6375
https://doi.org/10.1111/eth.12859
https://doi.org/10.1111/eth.12859
Autor:
Anna Rightmire, Beatriz Grinsztejn, Margaret Johnson, Kenneth A. Lichtenstein, Linda Odeshoo, Claudia Rodriguez, Edwin DeJesus, Victoria Wirtz, Jeffrey Coco, Adriano Lazzarin, Colin McLaren
Publikováno v:
AIDS (London, England). 20(5)
Background: In BMS Study 045, once-daily (QD) atazanavir/ritonavir (ATV/RTV) demonstrated comparable efficacy and safety to twice-daily (BID) lopinavir/ritonavir (LPV/RTV) over 48 weeks in treatment-experienced patients. Results of extended follow-up
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aefe98eb229c6ae5c7ab349819ef214
https://pubmed.ncbi.nlm.nih.gov/16514301
https://pubmed.ncbi.nlm.nih.gov/16514301
Autor:
Margaret Johnson, Serap Sankoh, R B Wilber, Edwin DeJesus, Jeffrey Coco, Adriano Lazzarin, Claudia Rodriguez, Kenneth A. Lichtenstein, Anna Rightmire, Beatriz Grinsztejn
Publikováno v:
Scopus-Elsevier
OBJECTIVE: To evaluate atazanavir/ritonavir (ATV/RTV) (300/100 mg) once daily, atazanavir/saquinavir (ATV/SQV) (400/1200 mg) once daily, and lopinavir/ritonavir (LPV/RTV) (400/100 mg) twice daily, each with tenofovir (300 mg) once daily and a nucleos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86e216183a48d12947cea5630f1ca24e
https://pubmed.ncbi.nlm.nih.gov/15821394
https://pubmed.ncbi.nlm.nih.gov/15821394